Yu OHY - Search Results

1

The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study.

Deng L, Aibibula W, Talat Z, Filion KB, Eintracht S, Dasgupta K, Tagalakis V, Majdan A, Yu OHY. Deng L, et al. Among authors: yu ohy. Endocrinol Diabetes Metab. 2021 May 27;4(3):e00268. doi: 10.1002/edm2.268. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277991 Free PMC article.

2

Incretin-based drugs and the risk of congestive heart failure.

Yu OH, Filion KB, Azoulay L, Patenaude V, Majdan A, Suissa S. Yu OH, et al. Diabetes Care. 2015 Feb;38(2):277-84. doi: 10.2337/dc14-1459. Epub 2014 Sep 9. Diabetes Care. 2015. PMID: 25205143

3

The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death.

Yu OH, Yin H, Azoulay L. Yu OH, et al. Can J Diabetes. 2015 Oct;39(5):383-9. doi: 10.1016/j.jcjd.2015.02.002. Epub 2015 Apr 1. Can J Diabetes. 2015. PMID: 25840943

4

The Influence of Proton-Pump Inhibitors on Glycemic Control: A Systematic Review of the Literature and a Meta-Analysis.

Gómez-Izquierdo JC, Yu OHY. Gómez-Izquierdo JC, et al. Among authors: yu ohy. Can J Diabetes. 2017 Aug;41(4):351-361. doi: 10.1016/j.jcjd.2016.11.004. Epub 2017 Mar 31. Can J Diabetes. 2017. PMID: 28373033 Review.

5

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S. Douros A, et al. Among authors: yu ohy. Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1. Diabetes Care. 2017. PMID: 28864502

6

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S. Douros A, et al. Among authors: yu ohy. BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693. BMJ. 2018. PMID: 30021781 Free PMC article.

7

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes.

Douros A, Rouette J, Yin H, Yu OHY, Filion KB, Azoulay L. Douros A, et al. Among authors: yu ohy. Diabetes Care. 2019 Aug;42(8):1496-1503. doi: 10.2337/dc19-0409. Epub 2019 Jun 10. Diabetes Care. 2019. PMID: 31182489

8

Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Suissa S. Douros A, et al. Among authors: yu ohy. Diabetes Obes Metab. 2020 Feb;22(2):254-262. doi: 10.1111/dom.13893. Epub 2019 Nov 3. Diabetes Obes Metab. 2020. PMID: 31596043

9

Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review.

Gómez-Izquierdo J, Filion KB, Boivin JF, Azoulay L, Pollak M, Yu OHY. Gómez-Izquierdo J, et al. Among authors: yu ohy. BMC Endocr Disord. 2020 Jun 9;20(1):83. doi: 10.1186/s12902-020-00566-9. BMC Endocr Disord. 2020. PMID: 32517676 Free PMC article.

10

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study.

Yu OHY, Dell'Aniello S, Shah BR, Brunetti VC, Daigle JM, Fralick M, Douros A, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ronksley PE, Filion KB, Ernst P, Lix LM; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Yu OHY, et al. Diabetes Care. 2020 Oct;43(10):2444-2452. doi: 10.2337/dc20-0267. Epub 2020 Aug 5. Diabetes Care. 2020. PMID: 32759360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters